Seth E. Karol

2.3k total citations
73 papers, 635 citations indexed

About

Seth E. Karol is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Seth E. Karol has authored 73 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 38 papers in Public Health, Environmental and Occupational Health and 25 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Seth E. Karol's work include Acute Lymphoblastic Leukemia research (38 papers), Acute Myeloid Leukemia Research (29 papers) and Childhood Cancer Survivors' Quality of Life (22 papers). Seth E. Karol is often cited by papers focused on Acute Lymphoblastic Leukemia research (38 papers), Acute Myeloid Leukemia Research (29 papers) and Childhood Cancer Survivors' Quality of Life (22 papers). Seth E. Karol collaborates with scholars based in United States, France and Germany. Seth E. Karol's co-authors include Ching‐Hon Pui, Mary V. Relling, Sima Jeha, Hiroto Inaba, Wenjian Yang, William E. Evans, Jeffrey E. Rubnitz, Kristine R. Crews, John C. Panetta and Cheng Cheng and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Seth E. Karol

61 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seth E. Karol United States 13 255 222 167 160 152 73 635
M V Relling United States 9 605 2.4× 307 1.4× 325 1.9× 254 1.6× 176 1.2× 14 877
Hassan El Solh Saudi Arabia 15 200 0.8× 179 0.8× 194 1.2× 192 1.2× 135 0.9× 33 641
Hester A. de Groot‐Kruseman Netherlands 16 662 2.6× 457 2.1× 402 2.4× 121 0.8× 173 1.1× 43 988
Margaret Masterson United States 15 263 1.0× 600 2.7× 137 0.8× 285 1.8× 139 0.9× 41 930
Kavitha M. Lakshmi India 19 286 1.1× 1.1k 4.8× 117 0.7× 662 4.1× 258 1.7× 105 1.4k
Virginia Bosó Spain 16 156 0.6× 74 0.3× 156 0.9× 118 0.7× 140 0.9× 40 628
Annelies E. van Ede Netherlands 10 342 1.3× 479 2.2× 46 0.3× 82 0.5× 40 0.3× 19 1.1k
NKC Ramsay United States 11 98 0.4× 239 1.1× 103 0.6× 62 0.4× 247 1.6× 11 630
Christopher Fraser Australia 13 194 0.8× 418 1.9× 154 0.9× 79 0.5× 261 1.7× 33 799
O Hartmann France 16 106 0.4× 185 0.8× 75 0.4× 111 0.7× 167 1.1× 40 668

Countries citing papers authored by Seth E. Karol

Since Specialization
Citations

This map shows the geographic impact of Seth E. Karol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth E. Karol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth E. Karol more than expected).

Fields of papers citing papers by Seth E. Karol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seth E. Karol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth E. Karol. The network helps show where Seth E. Karol may publish in the future.

Co-authorship network of co-authors of Seth E. Karol

This figure shows the co-authorship network connecting the top 25 collaborators of Seth E. Karol. A scholar is included among the top collaborators of Seth E. Karol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seth E. Karol. Seth E. Karol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steele, Lauren E., Nickhill Bhakta, Hiroto Inaba, et al.. (2025). Nutrition management of children with acute necrotizing pancreatitis following asparaginase: A case series. JPGN Reports. 6(4). 549–555.
2.
Eadon, Michael T., David W. Hein, Michael Asger Andersen, et al.. (2025). Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy. Clinical Pharmacology & Therapeutics. 118(6). 1430–1436.
3.
Umeda, Masayuki, Yen‐Chun Liu, Seth E. Karol, & Jeffery M. Klco. (2025). Novel classification system and high-risk categories of pediatric acute myeloid leukemia. Haematologica. 110(9). 1962–1973.
4.
Badawi, Mohamed, Sathej Gopalakrishnan, Tammy L. Palenski, et al.. (2024). Dosing of Venetoclax in Pediatric Patients with Relapsed Acute Myeloid Leukemia: Analysis of Developmental Pharmacokinetics and Exposure-Response Relationships. Clinical Therapeutics. 46(10). 759–767.
5.
Abramson, Zachary, Som Biswas, Sherwin S. Chan, et al.. (2024). Contrast enhanced ultrasound of liver lesions in patients treated for childhood malignancies. Cancer Imaging. 24(1). 115–115.
6.
Yang, Wenjian, Keito Hoshitsuki, Mary V. Relling, et al.. (2024). Clinical Actionability of the NUDT15 *4 (p.R139H) Allele and Its Association With Hispanic Ethnicity. Clinical Pharmacology & Therapeutics. 117(3). 724–731.
7.
8.
Lamba, Jatinder K., Huiyun Wu, Xueyuan Cao, et al.. (2023). Intensification of Therapy and Pharmacogenetic Personalization Mitigate Racial Disparities in Pediatric Acute Myeloid Leukemia Outcomes. Blood. 142(Supplement 1). 386–386. 1 indexed citations
9.
Hoshitsuki, Keito, Yinmei Zhou, John Choi, et al.. (2023). Rituximab administration in pediatric patients with newly diagnosed acute lymphoblastic leukemia. Leukemia. 37(9). 1782–1791. 4 indexed citations
10.
Lee, Shawn H. R., Wenjian Yang, Kathryn G. Roberts, et al.. (2023). Prognostic and Pharmacotypic Heterogeneity of Hyperdiploidy in Childhood ALL. Journal of Clinical Oncology. 41(35). 5422–5432. 7 indexed citations
11.
12.
Zheng, Yan, Wenjian Yang, Jeremie H. Estepp, et al.. (2023). Genomic analysis of venous thrombosis in children with acute lymphoblastic leukemia from diverse ancestries. Haematologica. 109(1). 53–59. 3 indexed citations
13.
Pfeiffer, Thomas, Ying Li, Seth E. Karol, et al.. (2022). Venetoclax-Based Combination Therapy As a Bridge to Allogeneic Hematopoietic Stem Cell Transplant in Children with Relapsed/Refractory AML. Transplantation and Cellular Therapy. 28(3). S120–S121. 2 indexed citations
14.
Marón, Gabriela, Diego R. Hijano, Rebecca Epperly, et al.. (2022). Infectious Complications in Pediatric, Adolescent and Young Adult Patients Undergoing CD19-CAR T Cell Therapy. Frontiers in Oncology. 12. 845540–845540. 15 indexed citations
15.
Panetta, John C., Yiwei Liu, Teodoro Bottiglieri, et al.. (2021). Pharmacodynamics of cerebrospinal fluid asparagine after asparaginase. Cancer Chemotherapy and Pharmacology. 88(4). 655–664. 7 indexed citations
16.
Karol, Seth E., Deqing Pei, Colton A. Smith, et al.. (2021). Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy. Haematologica. 107(2). 371–380. 8 indexed citations
17.
Williams, Hannah, Carrie R. Howell, Wassim Chemaitilly, et al.. (2019). Diabetes mellitus among adult survivors of childhood acute lymphoblastic leukemia: A report from the St. Jude Lifetime Cohort Study. Cancer. 126(4). 870–878. 19 indexed citations
18.
Karol, Seth E., Laura J. Janke, John C. Panetta, et al.. (2019). Asparaginase combined with discontinuous dexamethasone improves antileukemic efficacy without increasing osteonecrosis in preclinical models. PLoS ONE. 14(5). e0216328–e0216328. 8 indexed citations
19.
Ramsey, Laura B., Stanley Pounds, Cheng Cheng, et al.. (2017). Genetics of pleiotropic effects of dexamethasone. Pharmacogenetics and Genomics. 27(8). 294–302. 16 indexed citations
20.
Ramsey, Laura B., Laura J. Janke, Xiangjun Cai, et al.. (2015). Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia. PLoS ONE. 10(8). e0135134–e0135134. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M V Relling Breakdown of academic impact, for papers by Hassan El Solh Breakdown of academic impact, for papers by Hester A. de Groot‐Kruseman Breakdown of academic impact, for papers by Margaret Masterson Breakdown of academic impact, for papers by Kavitha M. Lakshmi Breakdown of academic impact, for papers by Virginia Bosó Breakdown of academic impact, for papers by Annelies E. van Ede Breakdown of academic impact, for papers by NKC Ramsay Breakdown of academic impact, for papers by Christopher Fraser Breakdown of academic impact, for papers by O Hartmann
Rankless by CCL
2026